Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could virtual reality ease the mental toll of ICU stays?

NCT ID NCT06267911

Symptom relief Sponsor: University of the Balearic Islands Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a non-immersive virtual reality program (RGS-ICU) for ICU patients. The program includes daily 20-minute sessions of cognitive exercises and psychological support alongside standard care. Researchers will enroll 93 adults in ICUs for respiratory failure, cardiogenic shock, or septic shock. The goal is to see if this approach improves comfort during the ICU stay and boosts thinking and mental health up to 12 months after discharge.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
non-immersive virtual reality-based cognitive stimulation and psychological support program (RGS-ICU)
What this could lead to
If it works, this could offer a safe, drug-free way to help ICU survivors recover thinking skills and emotional well-being, reducing long-term mental health issues.
What could go wrong
This is a small, early-stage trial with only 93 participants. The program may not show clear benefits over standard care, and some patients may not tolerate the sessions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

93 people

The number who actually took part.

Started

Sep 2024

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult patients (≥18 years) * Admitted to a medical/surgical ICU * For respiratory failure, cardiogenic shock, or septic shock * With an expected ICU stay of ≥48 hours * Residing in Catalonia or Majorca (Balearic Islands) * Who speak Catalan and/or Spanish * Who are able to give informed consent by themselves or through an authorized representative Exclusion Criteria: * History of intellectual disability or other neurodevelopmental disorders, such as autism spectrum disorder * History of neurological disorders, dementia or other neurodegenerative diseases, such as epilepsy, Alzheimer's disease, Parkinson's disease or multiple sclerosis * History of brain damage, such as traumatic brain injury or stroke * History of severe psychiatric illness, such as psychotic, bipolar, depressive, obsessive-compulsive, post-traumatic or personality disorder * Suspected or confirmed substance use disorder * Suspected or confirmed communicable disease in an isolated patient * Uncorrected hearing or visual impairment * Any medical condition that prevents safe upper extremity mobility, such as skin lesions, burns, or fractures * Life expectancy \<12 months * Enrolled in another trial that does not allow co-enrollment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Critical illness are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Critical Illness

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Critical illness

Contacts and locations

Locations

  • Corporacion Parc Tauli

    Sabadell, Catalonia, 08208, Spain

  • Hospital Universitari Son Llàtzer

    Palma de Mallorca, Balearic Islands, 07198, Spain

  • University of the Balearic Islands

    Palma de Mallorca, Balearic Islands, 07122, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.